C. Capparelli

Sustained Antiresorptive Effects After a Single Treatment With Human Recombinant Osteoprotegerin (OPG): A Pharmacodynamic and Pharmacokinetic Analysis in Rats

Steven W. Martin, P. Kostenuik, S. Morony, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature Osteoclasts

D. Lacey, M. Kelley, W. J. Boyle, 1999, The Journal of cell biology.

Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy.

P. Kostenuik, S. Morony, D. Lacey, 2000, Cancer research.